EDGAR Filing Documents for 0001564590-20-053628

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001564590-20-053628

Filing Date

2020-11-12

Accepted

2020-11-12 17:07:11

Documents

Period of Report

2020-11-12

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	lmnl-6k_20201112.htm	6-K	25837
2	EX-99.1	lmnl-ex991_6.htm	EX-99.1	77049
3	EX-99.2	lmnl-ex992_40.htm	EX-99.2	1495221
4	EX-99.3	lmnl-ex993_39.htm	EX-99.3	2679090
5	EX-99.4	lmnl-ex994_7.htm	EX-99.4	18697
6	EX-99.5	lmnl-ex995_8.htm	EX-99.5	19204
7	EX-99.6	lmnl-ex996_83.htm	EX-99.6	526799
8	GRAPHIC	ghdi1u4ioxo0000001.jpg	GRAPHIC	4060
9	GRAPHIC	grdzdx50r1iu000001.jpg	GRAPHIC	4060
10	GRAPHIC	gb5bly5djd4o000001.jpg	GRAPHIC	38195
	Complete submission text file	0001564590-20-053628.txt		4907260

Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4

Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115

Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)